Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - GB
$ 9.24
0.544 %
$ 41.8 B
Market Cap
28.88
P/E
Price Target
Average
--0.97%
Revenue Forecast
Estimate
13.65%
EBIT
Estimate
11.27%
Net Income
Estimate
62.42%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Haleon plc
Wall Street analysts predict an average 1-year price target for HLN of $9.15 , with forecasts ranging from
a
low of
$9.15 to a high of $9.15 .
HLN Lowest Price Target
Wall Street Target
9.15 USD
-0.97%
HLN Average Price Target
Wall Street Target
9.15 USD
-0.97%
HLN Highest Price Target
Wall Street Target
9.15 USD
-0.97%
REVENUE FORECAST
Revenue Forecast Chart HLN
EBIT FORECAST
EBIT Forecast Chart HLN
NET INCOME FORECAST
Net Income Chart HLN